Christopher J. Christie's most recent trade in Pacira BioSciences Inc was a trade of 11,279 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 11, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Pacira BioSciences Inc | Christopher J. Christie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 11,279 | 11,279 | - | - | Stock Option (Right to Buy) | |
Pacira BioSciences Inc | Christopher J. Christie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 6,163 | 16,654 (0%) | 0% | 0 | Common Stock | |
Pacira BioSciences Inc | Christopher J. Christie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 12,179 | 12,179 | - | - | Stock Option (Right to Buy) | |
Pacira BioSciences Inc | Christopher J. Christie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 5,230 | 10,491 (0%) | 0% | 0 | Common Stock | |
Pacira BioSciences Inc | Christopher J. Christie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 12,925 | 12,925 | - | - | Stock Option (Right to Buy) | |
Pacira BioSciences Inc | Christopher J. Christie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 1,775 | 5,261 (0%) | 0% | 0 | Common Stock | |
Pacira BioSciences Inc | Christopher J. Christie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 8,225 | 8,225 | - | - | Stock Option (Right to Buy) | |
Pacira BioSciences Inc | Christopher J. Christie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 1,160 | 3,486 (0%) | 0% | 0 | Common Stock |